The potential role of nonneutralizing antibody responses in HIV infection and prevention was put into the limelight when immune correlate studies from the RV144 trial identified an association between Env-gp120-specific IgG antibodies capable of mediating ADCC in vitro and a lower risk of infection (11, 47). The gene discussed is ERVW-1; the disease is infection.